www.entyvio.com Open in urlscan Pro
13.32.121.47  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Important Safety Information
 * Prescribing Information
 * Medication Guide
 * For Healthcare Professionals
 * Find Follow Watch

 * Home
 * * Important Safety Information
   * Prescribing Information
   * Medication Guide
   * For Healthcare Professionals
   * Find Follow Watch
 * * Privacy Notice
   * Terms of Use
   * Q&A
   * Site Map
   * Contact Us
   * Unsubscribe
   * Find Follow Watch

Click here for information on Coronavirus (COVID-19)

Please select your condition

Moderate to Severe
Ulcerative Colitis
Moderate to Severe
Crohn's Disease

Uses of ENTYVIO® (vedolizumab)

ENTYVIO is a prescription medicine used in adults for the treatment of:
 * moderately to severely active ulcerative colitis
 * moderately to severely active Crohn's disease

Please select your condition
ENTYVIO is for adults with moderate to severe ulcerative colitisCrohn's disease
when certain other medications haven't worked well enough or can't be tolerated.


USES OF ENTYVIO® (VEDOLIZUMAB)

ENTYVIO is a prescription medicine used in adults for the treatment of:

 * moderately to severely active ulcerative colitis
 * moderately to severely active Crohn’s disease




IMPORTANT SAFETY INFORMATION ABOUT ENTYVIO® (VEDOLIZUMAB)

 * Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any
   of its ingredients.
 * ENTYVIO may cause serious side effects, including:
   * Infusion-related and serious allergic reactions can happen while you are
     receiving ENTYVIO or several hours after treatment. You may need treatment
     if you have an allergic reaction. Tell your healthcare provider or get
     immediate medical help if you get any of these symptoms during or after an
     infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat
     or face, shortness of breath or trouble breathing, wheezing, dizziness,
     feeling hot, or palpitations (feel like your heart is racing).
   * ENTYVIO may increase your risk of getting a serious infection. Before
     receiving and during treatment with ENTYVIO, tell your healthcare provider
     if you think you have an infection or symptoms of an infection, such as
     fever, chills, muscle aches, cough, shortness of breath, runny nose, sore
     throat, red or painful skin or sores on your body, tiredness, or pain
     during urination.
   * People with weakened immune systems can get progressive multifocal
     leukoencephalopathy (PML) (a rare, serious brain infection caused by a
     virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be
     ruled out. PML can result in death or severe disability. There is no known
     treatment, prevention, or cure for PML. Tell your healthcare provider right
     away if you have any of the following symptoms: confusion or problems
     thinking, loss of balance, change in the way you walk or talk, decreased
     strength or weakness on one side of the body, blurred vision, or loss of
     vision.
   * Liver problems can happen in people who receive ENTYVIO. Tell your
     healthcare provider right away if you have any of the following symptoms:
     tiredness, loss of appetite, pain on the right side of your abdomen, dark
     urine, or yellowing of the skin and eyes (jaundice).
 * The most common side effects of ENTYVIO include common cold, headache, joint
   pain, nausea, fever, infections of the nose and throat, tiredness, cough,
   bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and
   pain in extremities. These are not all the possible side effects of ENTYVIO.
   Call your healthcare provider for medical advice about side effects.
 * Before receiving ENTYVIO, tell your healthcare provider about all of your
   medical conditions, including if you: have or think you may have an infection
   or have infections that keep coming back; have liver problems; have
   tuberculosis (TB) or have been in close contact with someone with TB; have
   recently received or are scheduled to receive a vaccine; or if you are
   pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Please see the full Prescribing Information, including the Medication Guide, for
ENTYVIO and talk with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


USES OF ENTYVIO® (VEDOLIZUMAB)

ENTYVIO is a prescription medicine used in adults for the treatment of:

 * moderately to severely active ulcerative colitis
 * moderately to severely active Crohn’s disease


IMPORTANT SAFETY INFORMATION ABOUT ENTYVIO® (VEDOLIZUMAB)

 * Do not receive ENTYVIO if you have had an allergic reaction to ENTYVIO or any
   of its ingredients.
 * ENTYVIO may cause serious side effects, including:
   * Infusion-related and serious allergic reactions can happen while you are
     receiving ENTYVIO or several hours after treatment. You may need treatment
     if you have an allergic reaction. Tell your healthcare provider or get
     immediate medical help if you get any of these symptoms during or after an
     infusion of ENTYVIO: rash, itching, swelling of your lips, tongue, throat
     or face, shortness of breath or trouble breathing, wheezing, dizziness,
     feeling hot, or palpitations (feel like your heart is racing).
   * ENTYVIO may increase your risk of getting a serious infection. Before
     receiving and during treatment with ENTYVIO, tell your healthcare provider
     if you think you have an infection or symptoms of an infection, such as
     fever, chills, muscle aches, cough, shortness of breath, runny nose, sore
     throat, red or painful skin or sores on your body, tiredness, or pain
     during urination.
   * People with weakened immune systems can get progressive multifocal
     leukoencephalopathy (PML) (a rare, serious brain infection caused by a
     virus). Although unlikely while receiving ENTYVIO, a risk of PML cannot be
     ruled out. PML can result in death or severe disability. There is no known
     treatment, prevention, or cure for PML. Tell your healthcare provider right
     away if you have any of the following symptoms: confusion or problems
     thinking, loss of balance, change in the way you walk or talk, decreased
     strength or weakness on one side of the body, blurred vision, or loss of
     vision.
   * Liver problems can happen in people who receive ENTYVIO. Tell your
     healthcare provider right away if you have any of the following symptoms:
     tiredness, loss of appetite, pain on the right side of your abdomen, dark
     urine, or yellowing of the skin and eyes (jaundice).
 * The most common side effects of ENTYVIO include common cold, headache, joint
   pain, nausea, fever, infections of the nose and throat, tiredness, cough,
   bronchitis, flu, back pain, rash, itching, sinus infection, throat pain, and
   pain in extremities. These are not all the possible side effects of ENTYVIO.
   Call your healthcare provider for medical advice about side effects.
 * Before receiving ENTYVIO, tell your healthcare provider about all of your
   medical conditions, including if you: have or think you may have an infection
   or have infections that keep coming back; have liver problems; have
   tuberculosis (TB) or have been in close contact with someone with TB; have
   recently received or are scheduled to receive a vaccine; or if you are
   pregnant, breastfeeding, plan to become pregnant, or plan to breastfeed.

Please see the full Prescribing Information, including the Medication Guide, for
ENTYVIO and talk with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


USES OF ENTYVIO® (VEDOLIZUMAB)

ENTYVIO is a prescription medicine used in adults for the treatment of:

 * moderately to severely active ulcerative colitis
 * moderately to severely active Crohn’s disease

Back to Top

This site is intended for use by U.S. residents only.

 * Privacy Notice
 * Terms of Use
 * Q&A
 * Site Map
 * Contact Us
 * Unsubscribe
 * Find Follow Watch

ENTYVIO is a trademark of Millennium Pharmaceuticals, Inc., registered with the
U.S. Patent and Trademark Office and is used under license by
Takeda Pharmaceuticals U.S.A., Inc. All other trademarks are the property of
their respective owners.

©2022 Takeda Pharmaceuticals U.S.A., Inc. US-VED-1505v2.0     07/22

Close

YOU ARE ABOUT TO LEAVE THIS WEBSITE AND ENTER A WEBSITE OPERATED BY AN
INDEPENDENT THIRD PARTY

The links to third-party websites contained on this website are provided solely
for your convenience. Takeda does not control the content contained on any
third-party website linked from this website. Your activities at those websites
will be governed by the policies and practices of those third parties.

Please select "Continue" if you wish to be taken to this third-party website.

Cancel Continue
Close

YOU ARE ABOUT TO LEAVE THIS WEBSITE.

Cancel Continue
Close

Close

Close

SHARE WITH YOUR FRIENDS AND FAMILY: